Cell MedX Net income (Q3, 2019)-390.7 K
Cell MedX Cash, 28-Feb-2019130.9 K

Cell MedX Funding

Summary Metrics

Founding Date

2014

Cell MedX Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

42.6k36.6k6.2k

Cost of goods sold

26.6k28.4k4.1k

Gross profit

16.1k8.1k2.2k

Gross profit Margin, %

38%22%35%

R&D expense

297.0k418.3k

General and administrative expense

12.6k18.5k300.5k241.7k400.3k235.3k

Operating expense total

12.6k18.5k1.0m2.1m1.2m1.5m

Interest expense

32.8k29.1k11.2k

Net Income

(12.6k)(18.5k)(1.0m)(2.1m)(1.2m)(1.5m)

Cell MedX Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(12.6k)(18.5k)(1.0m)(2.1m)(1.2m)(1.5m)

Inventories

(729.0)(3.9k)(4.3k)(6.0k)

Accounts Payable

1.9k222.8k136.3k85.3k146.3k

Purchases of PP&E

(27.8k)(218.8k)110.2k

Cash From Investing Activities

(27.8k)(218.8k)(110.2k)

Cash From Financing Activities

345.2k666.8k904.2k388.1k

Cell MedX Ratios

USDY, 2019

Financial Leverage

-0.1 x